Medtronic plc Stock

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:02 2024-05-10 EDT 5-day change 1st Jan Change
82.84 USD +0.10% Intraday chart for Medtronic plc +1.41% +0.56%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 32.24B 44.07B Sales 2025 * 33.57B 45.89B Capitalization 110B 150B
Net income 2024 * 4.56B 6.23B Net income 2025 * 5.24B 7.17B EV / Sales 2024 * 4.1 x
Net Debt 2024 * 22.21B 30.36B Net Debt 2025 * 21.12B 28.87B EV / Sales 2025 * 3.91 x
P/E ratio 2024 *
23.6 x
P/E ratio 2025 *
20.5 x
Employees 95,000
Yield 2024 *
3.32%
Yield 2025 *
3.49%
Free-Float 99.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.10%
1 week+1.41%
Current month+3.24%
1 month+0.62%
3 months-2.53%
6 months+17.20%
Current year+0.56%
More quotes
1 week
81.26
Extreme 81.26
83.06
1 month
78.43
Extreme 78.43
83.06
Current year
78.43
Extreme 78.43
89.18
1 year
68.84
Extreme 68.84
91.00
3 years
68.84
Extreme 68.84
135.89
5 years
68.84
Extreme 68.84
135.89
10 years
55.54
Extreme 55.54
135.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 15-01-25
Director of Finance/CFO 58 16-05-31
Chief Operating Officer 63 21-03-31
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 70 06-12-31
Director/Board Member 68 14-12-31
More insiders
Date Price Change Volume
24-05-10 82.84 +0.10% 4,217,841
24-05-09 82.76 +1.48% 5,545,720
24-05-08 81.55 -0.43% 4,175,665
24-05-07 81.9 +0.17% 4,939,733
24-05-06 81.76 +0.09% 3,676,174

Delayed Quote Nyse, May 10, 2024 at 04:00 pm

More quotes
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
82.84 USD
Average target price
94.77 USD
Spread / Average Target
+14.41%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW